Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure

Pediatric Nephrology

Volumn 20, Issue 3 SPEC. ISS., 2005, Pages 290-294

  Clark, Ross G ^a  

^a Tercica Inc   (United States)

Author keywords

Combination therapy; Growth hormone; Insulin like growth factor 1; Renal failure; Short stature

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN; SOMATOMEDIN C;

CHILD; CHRONIC KIDNEY FAILURE; DRUG EFFICACY; DRUG POTENTIATION; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; GROWTH RETARDATION; HORMONAL REGULATION; HUMAN; HYPOGLYCEMIA; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; SHORT STATURE; SIGNAL TRANSDUCTION;

CHILD; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE;

EID: 14644394915     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1714-7     Document Type: Review

References (29)

1. Daughaday WH (1989) A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med 32:194-211
2. Salmon WD Jr, Daughaday WH (1990) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 116:408-419
3. Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776
4. Isaksson OG, Jansson JO, Gause IA (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216:1237-1239
5. Isaksson OG, Lindahl A, Nilsson A, Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438
6. Skottner A, Clark RG, Robinson IC, Fryklund L (1987) Recombinant human insulin-like growth factor: Testing the somatomedin hypothesis in hypophysectomized rats. J Endocrinol 112:123-132
7. Laron Z (1999) The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 84:4397-4404
8. Mehls O, Schaefer F, Tonshoff B (2003) Growth disorders in chronic renal failure. Oxford PharmaGenesis, Oxford, pp 1-119
9. Powell-Braxton L, Hollingshead P, Giltinan D, Pitts-Meek S, Stewart T (1993) Inactivation of the IGF-I gene in mice results in perinatal lethality. Ann N Y Acad Sci 692:300-301
10. Liu JL, Yakar S, LeRoith D (2000) Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system. Proc Soc Exp Biol Med 223:344-351
11. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367 10.1056/NEJM199610313351805
12. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092
13. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
14. LeRoith D, Bondy C, Yakar S, Liu J-L, Butler A (2001) The somatomedin hypothesis: 2001. Endocr Rev 22:53-74 10.1210/er.22.1.53
15. Clark RG, Robinson IC (1996) Up and down the growth hormone cascade. Cytokine Growth Factor Rev 7:65-80
16. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854 10.1210/er.2001-0033
17. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781 10.1172/JCI200215463
18. Tonshoff B, Blum WF, Wingen AM, Mehls O (1995) Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Clin Endocrinol Metab 80:2684-2691 10.1210/ jc.80.9.2684
19. Tonshoff B, Veldhuis JD, Heinrich U, Mehls O (1995) Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res 37:86-93
20. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162 10.1006/dbio.2000.9975
21. Clark RG, Mortensen DL, Carlsson LMS (1995) Insulin-like growth factor-1 and growth hormone (GH) have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine 3:297-304
22. Clark RG, Thomas GB, Mortensen DL, Won WB, Ma YH, Tomlinson EE, Fairhall KM, Robinson IC (1997) Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Endocrinology 138:4316-4323
23. Rosenfeld RG (1996) Biochemical diagnostic strategies in the evaluation of short stature: The diagnosis of insulin-like growth factor deficiency. Horm Res 46:170-173
24. Attie KM, Carlsson LM, Rundle AC, Sherman BM (1995) Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. J Pediatr 127:244-250
25. Rogol AD, Blethen SL, Sy JP, Veldhuis JD (2003) Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy? Clin Endocrinol (Oxf) 58:229-237
26. Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA (1994) Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58-68
27. Kovacs GT, Oh J, Kovacs J, Tonshoff B, Hunziker EB, Zapf J, Mehls O (1996) Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 49:1413-1421 1:CAS:528:DyaK28Xkslagtrw%3D
28. Vijayan A, Franklin SC, Behrend T, Hammerman MR, Miller SB (1999) Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure. Am J Physiol 276:R929-R934
29. Guler HP, Schmid C, Zapf J, Froesch ER (1989) Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86:2868-2872